Agilon Health (AGL)
NYSE:AGL
Want to see AGL full AI Analyst Report?
AGL Stock Chart & Stats
$30.05
$0.02(1.16%)
At close: 4:00 PM EST
$30.05
$0.02(1.16%)
Day’s Range― - ―
52-Week Range$7.48 - $119.50
Previous CloseN/A
Volume1.09M
Average Volume (3M)273.15K
Market Cap
$463.98M
Enterprise Value$354.01M
Total Cash (Recent Filing)$285.14M
Total Debt (Recent Filing)$36.81M
Price to Earnings (P/E)1.1
Beta2.27
Next Earnings
Jul 30, 2026EPS Estimate
-0.66Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-23.75
Shares Outstanding16,659,819
10 Day Avg. Volume427,095
30 Day Avg. Volume273,151
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.25
Price to Sales (P/S)0.05
P/FCF Ratio-2.40
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue0.06
Enterprise Value/Gross Profit-2.03
Enterprise Value/Ebitda-0.96
Forecast
1Y Price Target
$26.39Price Target Upside-12.18% Downside
Rating ConsensusHold
Number of Analyst Covering15
EPS Forecast (FY)-5.38
Revenue Forecast (FY)$5.45B
Bulls Say, Bears Say
Bulls Say
Liquidity And Cash RunwayAnalyst points to an extended credit facility and an expected cash balance that should provide runway while profitability recovers amid medical cost and regulatory uncertainty.
Medicare Advantage RatesAnalyst notes stronger-than-expected Medicare Advantage rates and smaller chart review impacts could allow plans to adjust benefits, recapture margin, and improve earnings potential.
Prescription Drug Benefit ExposureAnalyst highlights reduced exposure to the prescription drug benefit as a way to lower margin risk and support more stable profitability.
Bears Say
Guidance Visibility And Profitability MissesAnalyst flags that adjusted EBITDA results fell short of expectations and ongoing difficulties in forecasting costs create uncertainty around guidance and the company's cash position.
Membership Exits And Start-up CostsAnalyst notes planned exits from certain Medicare Advantage contracts and transitions of care lives into other programs could reduce membership and weigh on near-term profitability due to start-up costs.
Rising Medical Costs And Prior-year AdjustmentsAnalyst cautions that a high medical cost trend and potential unfavorable prior-year adjustments could pressure profitability and hinder margin recovery.
Agilon Health News
AGL FAQ
What was Agilon Health’s price range in the past 12 months?
Agilon Health lowest stock price was $7.48 and its highest was $119.50 in the past 12 months.
What is Agilon Health’s market cap?
Agilon Health’s market cap is $463.98M.
When is Agilon Health’s upcoming earnings report date?
Agilon Health’s upcoming earnings report date is Jul 30, 2026 which is in 84 days.
How were Agilon Health’s earnings last quarter?
Agilon Health released its earnings results on May 06, 2026. The company reported $1.8 earnings per share for the quarter, beating the consensus estimate of $1.041 by $0.759.
Is Agilon Health overvalued?
According to Wall Street analysts Agilon Health’s price is currently Overvalued.
Does Agilon Health pay dividends?
Agilon Health pays a Quarterly dividend of $0.45 which represents an annual dividend yield of N/A. See more information on Agilon Health dividends here
What is Agilon Health’s EPS estimate?
Agilon Health’s EPS estimate is -0.66.
How many shares outstanding does Agilon Health have?
Agilon Health has 16,659,819 shares outstanding.
What happened to Agilon Health’s price movement after its last earnings report?
Agilon Health reported an EPS of $1.8 in its last earnings report, beating expectations of $1.041. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Agilon Health?
Currently, no hedge funds are holding shares in AGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilon Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$26.39 (-12.18% Downside)
$26.39 (-12.18% Downside)
Blogger Sentiment
Bullish
AGL Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 7.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 9.2%
Last 30 Days ▲ 9.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.95%
12-Months-Change
Fundamentals
Return on Equity
-116.65%
Trailing 12-Months
Asset Growth
-26.68%
Trailing 12-Months
Company Description
Agilon Health
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
AGL Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a balanced message: strong operational execution and meaningful near-term wins (data pipeline, risk adjustment upside, improved medical margin, scaled clinical programs and a sizable Q1 adjusted EBITDA beat) were tempered by structural challenges — notably a sizable year-over-year MA membership decline, a YoY revenue decline, Part D reserving uncertainty, cautious early-year cost recording, and conservative full-year adjusted EBITDA guidance. Management emphasized disciplined, sustainable growth and quality-driven improvements rather than aggressive expansion, resulting in positive operational momentum but continued near-term prudence and uncertainty.View all AGL earnings summariesAGL Stock 12 Month Forecast
Average Price Target
$26.39
▼(-12.18% Downside)
Technical Analysis
AMN Healthcare Services
―
Cross Country Healthcare
―
InnovAge Holding
―
P3 Health Partners
―
biote
―
Ownership Overview
Currently, No data available
---